Dementia is not a disease. It’s an umbrella term for a range of symptoms, including memory loss, impaired reasoning, and difficulty with daily tasks. Alzheimer’s disease is one specific disease that causes dementia, and it’s the most common one, contributing to 60 to 70 percent of all dementia cases. The simplest way to think about it: all Alzheimer’s is dementia, but not all dementia is Alzheimer’s.
How Dementia Works as a Category
Dementia describes a set of symptoms severe enough to interfere with everyday life. These include declining memory, poor judgment, difficulty with language, reduced attention, and changes in behavior. Many different brain conditions produce these symptoms, and the specific pattern depends on which parts of the brain are damaged and why.
Some of the most common types beyond Alzheimer’s include vascular dementia, Lewy body dementia, and frontotemporal dementia. Each has distinct causes, affects different brain regions first, and produces a recognizable pattern of early symptoms. Identifying which type someone has matters because it shapes the treatment approach, the likely progression, and what to expect day to day.
What Makes Alzheimer’s Different
Alzheimer’s disease is defined by two specific abnormalities in the brain: amyloid plaques and neurofibrillary tangles. Amyloid plaques are clumps of a protein called beta amyloid that build up in the tissue between nerve cells. Neurofibrillary tangles form inside neurons when a protein called tau becomes misshapen and twists into bundles. Tau normally helps maintain the internal transport system that nerve cells rely on to function. When it collapses, cells can no longer communicate effectively and eventually die.
Because Alzheimer’s first attacks the part of the brain involved in learning, the earliest symptoms are almost always changes in memory and reasoning. Someone might repeatedly forget recent conversations, struggle with planning, or lose track of dates and appointments. This is a useful distinction: other dementias often show up differently at first.
How Other Types of Dementia Look Different
Vascular dementia results from disrupted blood flow to the brain, often from blood clots or small strokes. It can cause forgetfulness and poor judgment, but the onset is sometimes sudden rather than gradual, and symptoms may worsen in noticeable steps rather than a slow decline.
Lewy body dementia involves abnormal deposits of a protein called alpha-synuclein. Its hallmark features set it apart clearly: vivid visual hallucinations, significant fluctuations in alertness and attention throughout the day, muscle rigidity, reduced facial expression, and sleep disturbances including excessive daytime drowsiness. Memory problems are present but not always the first thing people notice.
Frontotemporal dementia affects the frontal and temporal lobes, which govern personality, behavior, and language. Early symptoms tend to be behavioral rather than memory-related. Someone might become impulsive, emotionally flat, or have increasing difficulty producing or understanding speech. It also tends to strike earlier, often in the 40s to 60s, while Alzheimer’s is more common after 65.
How Each Is Diagnosed
A general dementia diagnosis starts with cognitive testing, a medical history review, and ruling out other causes. But pinpointing the specific type requires more targeted investigation. For Alzheimer’s specifically, the diagnostic standard has shifted in recent years toward biological confirmation. Updated 2024 criteria from the Alzheimer’s Association define the disease biologically, not just by its symptoms, meaning diagnosis relies on detecting the characteristic protein abnormalities through biomarkers.
These biomarkers can be measured through brain imaging or fluid tests. Cerebrospinal fluid analysis and specialized brain scans have been the standard tools, and newer blood-based biomarker tests are now being validated for clinical use. This is a significant shift: it means Alzheimer’s can increasingly be confirmed while someone is alive rather than only at autopsy, and it can be distinguished from other dementias more precisely.
Conditions That Mimic Dementia
Not every case of memory loss and confusion is irreversible. Several treatable conditions produce symptoms that look like dementia but can improve or resolve entirely with the right treatment. Depression is a common culprit, especially in older adults, where it can cause withdrawal, fatigue, and foggy thinking that closely resembles cognitive decline. Vitamin B-12 deficiency, poor nutrition, certain infections like Lyme disease, heavy alcohol use, and even medication interactions can all impair brain function in ways that appear to be dementia. Heart and lung diseases that reduce oxygen supply to the brain can have similar effects. These possibilities are exactly why a thorough medical evaluation matters before assuming any form of permanent dementia.
How Alzheimer’s Progresses Over Time
Alzheimer’s follows a broadly predictable path through five stages, though the speed varies enormously between individuals. The disease begins with a preclinical phase where changes are happening in the brain but no symptoms are noticeable. This silent stage can last years or even decades. It then moves into mild cognitive impairment, where memory and thinking changes are present but subtle enough that they don’t significantly disrupt work or relationships.
The mild dementia stage is when most people receive a diagnosis. Memory and thinking problems become obvious to family and start interfering with daily functioning. In the moderate stage, confusion deepens and people need increasing help with self-care and routine activities. The severe stage brings further mental and physical decline.
On average, people with Alzheimer’s live between 3 and 11 years after diagnosis, though some live 20 years or more. How far the disease has advanced at the time of diagnosis plays a significant role in that range.
Treatment Differences
Because different dementias have different causes, treatments are not interchangeable. The newest Alzheimer’s treatments target the disease’s specific biology. The FDA has approved medications that work by clearing amyloid plaques from the brain. These are given as intravenous infusions every four weeks and are intended for people in the early stages, with mild cognitive impairment or mild dementia. In clinical trials, treated patients showed a meaningful slowing of cognitive and functional decline compared to those receiving a placebo.
These amyloid-targeting treatments only apply to Alzheimer’s, not to other forms of dementia, because they address a mechanism unique to the disease. Other types of dementia are managed differently depending on their cause. Vascular dementia treatment focuses on controlling the cardiovascular risk factors driving it. Lewy body dementia requires careful medication choices because some drugs that help other dementias can worsen its symptoms. This is one of the most practical reasons why getting the right diagnosis matters: the wrong treatment can be ineffective or even harmful.